Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease
I Califano, A Smulever, F Jerkovich, F Pitoia - Reviews in Endocrine and …, 2024 - Springer
Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly
patients. There is often a history of previous differentiated thyroid cancer suggesting a …
patients. There is often a history of previous differentiated thyroid cancer suggesting a …
Multikinase inhibitor treatment in thyroid cancer
Thyroid cancer is the most common endocrine malignancy. Most thyroid cancer types
respond well to conventional treatment consisting of surgery and radioactive iodine (RAI) …
respond well to conventional treatment consisting of surgery and radioactive iodine (RAI) …
Non-coding RNA in thyroid cancer-Functions and mechanisms
Thyroid cancer is the most common endocrine malignant tumor, and its incidence has
increased significantly in the past few years. A growing number of noncoding RNAs …
increased significantly in the past few years. A growing number of noncoding RNAs …
Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults
K Horiguchi, Y Yoshida, K Iwaku, N Emoto… - Endocrine …, 2021 - jstage.jst.go.jp
The incidence of thyroid carcinoma has been increasing worldwide. This is interpreted as an
increase in the incidental detection of papillary thyroid microcarcinomas (PTMCs). However …
increase in the incidental detection of papillary thyroid microcarcinomas (PTMCs). However …
[HTML][HTML] Role of succinylation modification in thyroid cancer and breast cancer
R Mu, Z Ma, C Lu, H Wang, X Cheng… - American Journal of …, 2021 - ncbi.nlm.nih.gov
The incidence of thyroid cancer and breast cancer is increasing year by year, and the
specific pathogenesis is unclear. Posttranslational modifications constitute an important …
specific pathogenesis is unclear. Posttranslational modifications constitute an important …
[HTML][HTML] Update on current diagnosis and management of anaplastic thyroid carcinoma
ET Pavlidis, IN Galanis, TE Pavlidis - World Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Well-differentiated thyroid carcinoma has a favorable prognosis with a 5-year survival rate of
over 95%. However, the undifferentiated or anaplastic type accounting for< 0.2%, usually in …
over 95%. However, the undifferentiated or anaplastic type accounting for< 0.2%, usually in …
The risk of perchlorate and iodine on the incidence of thyroid tumors and nodular goiter: a case-control study in southeastern China
H Wang, Y Jiang, J Song, H Liang, Y Liu, J Huang… - Environmental …, 2022 - Springer
Background The incidence rates of thyroid tumors and nodular goiter show an upward trend
worldwide. There are limited reports on the risk of perchlorate and iodine on thyroid tumors …
worldwide. There are limited reports on the risk of perchlorate and iodine on thyroid tumors …
Poorly differentiated and anaplastic thyroid cancer: Insights into genomics, microenvironment and new drugs
A Prete, A Matrone, C Gambale, L Torregrossa… - Cancers, 2021 - mdpi.com
Simple Summary In the last decades, many researchers produced promising data
concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer …
concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer …
Risk factors for recurrence of follicular thyroid cancer: a systematic review
Background: In risk assessment of recurrence, papillary thyroid cancer (PTC) and follicular
thyroid cancer (FTC) are often grouped together as differentiated thyroid cancer (DTC) …
thyroid cancer (FTC) are often grouped together as differentiated thyroid cancer (DTC) …
Influence of thyroid-stimulating hormone suppression therapy on bone mineral density in patients with differentiated thyroid cancer: a meta-analysis
Background The effects of subclinical hyperthyroidism on bone mineral density (BMD)
induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with …
induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with …